Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor
Author:
Affiliation:
1. Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
2. Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.5b00102
Reference27 articles.
1. p21-Activated kinases: three more join the Pak
2. UnPAKing the class differences among p21-activated kinases
3. p21-activated kinases in cancer
4. PAK signalling during the development and progression of cancer
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis and biological evaluation of a novel PAK1 degrader for the treatment of triple negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10
2. Prediction of Protein Allosteric Sites with Transfer Entropy and Spatial Neighbor-Based Evolutionary Information Learned by an Ensemble Model;Journal of Chemical Information and Modeling;2024-07-30
3. Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model;Cancer Science;2024-06-19
4. Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics;MedComm – Oncology;2024-03
5. Development of Selective Pyrido[2,3-d]pyrimidin-7(8H)-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors;Journal of Medicinal Chemistry;2024-02-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3